Analyst Insights - Digital Health Posts

Read our Analysts’ insights and expert opinions on the latest healthcare technology industry developments and market trends. Signify Research provides both free insights and premium insights which are only available to subscribers of "Signify Premium Insights".
Click on the premium insights link below to filter for just the premium content.



Strength in Union: Medica and Vital Radiology’s Partnerships to Bolster NHS

11th October 2021 – Two key deals, involving four of the UK and Oceania’s teleradiology providers, were announced in early 2021. Signify Research provides its take on these deals in this insight.

Signify Premium Insight: Philips’ Future Vision for Imaging: Digital Platforms, Service Line Efficiency & Long-Term Partnerships

Signify Premium Insights Subscription Required

7th October 2021 – At a recent analyst day, Philips detailed how it will transition to a digital future, in which a greater proportion of revenues are derived from services. This Premium Insight explores the strategy and highlights its key facets.

Signify Premium Insight: Addressing the Shortcomings of AI

Signify Premium Insights Subscription Required

5th October 2021 – A recent study appeared to dampen the excitement for medical imaging AI after concluding that some breast screening tools were a long way from having the quality or quantity of evidence required for their adoption into clinical practice. This Premium Insight adds context to this verdict and considers the other factors at play.

Signify Premium Insight: GE Healthcare’s Billion on BK Medical

Signify Premium Insights Subscription Required

4th October 2021 – GE Healthcare surprised many when it revealed it had acquired BK Medical. The deal marks the Boston-based company’s first major acquisition in several years. This Premium Insight assesses the prospects for the move.

Signify Premium Insight: The Funding of Infervision’s Opportunity

Signify Premium Insights Subscription Required

29th September 2021 – Medical imaging AI vendor Infervision has, this year, secured $139m in Series D funding. This amount, added to what it has already raised, secures the vendor’s position as one of the world’s best-funded medical imaging AI outfits. But, where does it go from here?